Xori's Series A Round

Xori raised a round of funding on May 22, 2009.

XORI Corp. is a development stage company focused on a technology for the rapid discovery and development of therapeutic monoclonal antibodies for oncology, immune disorders and infectious disease.…

Articles about Xori's Series A Round: